Articles
Time for pharma supply chain to deliver real value?

Time for pharma supply chain to deliver real value?

As pharma looks for renewed efficiency in all areas, Johnathon Marshall and Alison Wilson assess what the future may hold for supply chain in the industry. Pharmaceutical companies are facing an ever increasing number of challenges as they look to maintain...

Articles
Minimising risks: drug discovery practices for Chief Scientific Officers

Minimising risks: drug discovery practices for Chief Scienti...

pharmaphorum invites feedback from our readers on the recent interview marcus evans conducted with Malcolm Weir, CEO of Heptares Therapeutics, discussing the challenges of drug discovery today. Statistics seem almost stacked against developing a fitting drug for a target disease. Drug discovery is plagued by time consuming and costly...

Articles
What Are IDEAs Made Of: Research

What Are IDEAs Made Of: Research

This week Mike Rea is asking about the purpose of research and how it should be directed to deliver truly great insight that is of real value. It has been said that the definition of madness is to keep doing the same thing again and expect a different outcome. This doesn't seem to apply to market research. There is a thought in play that if you ask doctors what they want...

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more